Abstract
Elevated BMI has been shown to have a negative impact on male fertility. Clomiphene citrate (CC), a selective estrogen receptor modulator, is often used in the empiric treatment of subfertile males to increase testosterone levels and improve spermatogenesis. The objective of this study was to assess the effect of CC in the treatment of subfertile males with elevated BMI ≥ 25 kg/m2.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
